A Promising Trial Targets a Genetic Risk for Alzheimer’s
Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.
Continue Reading https://www.nytimes.com
Additional Contributions:
Join the Discussion